Policy Maker

With facts and figures about health status, behavioral risk factors, mortality, and access to care, the resource aims to inform rural health policy for four states – Arizona, California, New Mexico, and Texas – along the U.S. southern border.  The chartbook is a collaboration between the FORHP-supported Rural & Minority Health Research Center and the National Rural Health Association.

This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support people in recovery.

State policymakers are interested in learning about the most effective treatments to address OUD and avoid unintended consequences such as overdose events, mortality from overdose, and use of illicit and unregulated drugs. This article describes the lack of evidence surrounding the use of Medically Supervised Withdrawal as a standalone “treatment.”

The RCORP-TA Policy Academy Town Hall took place on September 1, 2020. Please find the presentation and recording posted here.

The American Medical Association’s Opioid Task Force report shows a dramatic increase in fatalities involving illicit opioids, stimulants (e.g. methamphetamine), heroin and cocaine and a similarly dramatic drop in the use of prescription opioids.

The "Navigating System Cultures across the Sequential Intercept Model (SIM)" webinar, held on June 26, 2020, and hosted by SAMHSA's GAINS Center.